Mucosolvan (main component is ambroxol), can improve syntheses and release of pulmonary surfactant, is a clinical respiratory mucolysate.
2．沐舒坦，主要活性成分是盐酸氨溴索，能促进肺泡表面活性物质的合成和释放，是一种临床呼吸道粘液溶解剂。
参考来源 - 大鼠肺缺血再灌注损伤中肺泡细胞凋亡及沐舒坦的保护作用·2,447,543篇论文数据，部分数据来源于NoteExpress
Objective To study the effect of Mucosolvan on management of lung infection in the patients after severe brain injury.
目的探讨盐酸氨溴索对控制重型颅脑损伤患者肺部感染的作用。
Objective To evaluate the clinic effect of using Mucosolvan on the treatment of acute aggravation period of Chronic Pulmonary Heart Disease.
目的探讨沐舒坦佐治慢性肺源性心脏病急性加重期的临床疗效。
Objective To investigate the therapeutic effect of large dose mucosolvan combined variant flow rate continuous positive airway by nasal mask on neonatal respiratory distress syndrome(NRDS).
目的探讨大剂量盐酸氨溴索（沐舒坦）联合新型鼻罩持续呼吸道正压通气治疗新生儿呼吸窘迫综合征（NRDS）的疗效。
应用推荐